Is NRSN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NRSN. It does not provide personalized investment advice.

NRSN (NeuroSense Therapeutics Ltd. Ordinary Shares) Stock Analysis - Financials

NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) is a publicly traded Healthcare sector company. As of July 22, 2026, NRSN trades at $0.65 with a market cap of $24.89M and a P/E ratio of 0.00. NRSN moved -7.14% today. Year to date, NRSN is -8.97%; over the trailing twelve months it is -63.73%. Its 52-week range spans $0.63 to $2.60. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NRSN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NRSN's key financials?

NRSN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRSN recently traded at $0.65. Market cap is $24.89M. P/E ratio is 0.00. Revenue is $0.

NRSN Key Metrics

Key financial metrics for NRSN
Metric	Value
Price	$0.65
Market Cap	$24.89M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$2.60
52-Week Low	$0.63
Volume	118.89K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

NRSN Analyst Consensus

2 analysts cover NRSN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.

Common questions about NRSN

What are NRSN's key financials?: NRSN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRSN recently traded at $0.65. Market cap is $24.89M. P/E ratio is 0.00. Revenue is $0.
Is NRSN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NRSN. It does not provide personalized investment advice.